The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Digestive Diseases

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000282083PMID 20460908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin resistance, inflammation, and non-alcoholic fatty liver disease.

  2008cited by this paper
• A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance

  2008cited by this paper
• Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

  2007cited by this paper
• Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.

  2006cited by this paper
• Bacterial translocation and its consequences in patients with cirrhosis

  2005cited by this paper
• Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli.

  2005cited by this paper
• Adiponectin is synthesized and secreted by human and murine cardiomyocytes

  2005cited by this paper
• Inflammation, stress, and diabetes.

  2005cited by this paper
• Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

  2005cited by this paper
• Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.

  2004cited by this paper
• Adiponectin differentially regulates cytokines in porcine macrophages.

  2004cited by this paper
• Adiponectin and its receptors in non-alcoholic steatohepatitis

  2004cited by this paper
• Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice.

  2004cited by this paper
• Adiponectin protects LPS‐induced liver injury through modulation of TNF‐α in KK‐Ay obese mice

  2004cited by this paper
• Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies.

  2004cited by this paper
• Beyond insulin resistance in NASH: TNF‐α or adiponectin?

  2004cited by this paper
• Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages

  2004cited by this paper
• Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

  2004cited by this paper
• The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

  2003cited by this paper
• Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

  2003cited by this paper
• Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.

  2003cited by this paper
• Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

  2003cited by this paper
• Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.

  2003cited by this paper
• Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.

  2003cited by this paper
• Interleukin-6-deficient mice develop mature-onset obesity

  2002cited by this paper
• NASH: From liver diseases to metabolic disorders and back to clinical hepatology

  2002cited by this paper
• Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

  2002cited by this paper
• Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.

  2001cited by this paper
• Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients

  2001cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

  2000cited by this paper
• Cytokines in alcoholic and nonalcoholic steatohepatitis.

  2000cited by this paper
• Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

  1999cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-α function

  1997cited by this paper
• AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*)

  1996cited by this paper
• Interleukin-6 family of cytokines and gp130.

  1995cited by this paper
• A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*)

  1995cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• Preliminary evidence that adipose tissue contributes to serum proprotein convertase subtilisin/kexin type 9 levels in murine models of metabolic liver injury.

  2026cites this paper
• Immunonutrition: Another Player on the MASLD Field

  2025cites this paper
• NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DISEASE MECHANISMS AND CONTEMPORARY THERAPEUTIC APPROACHES - A LITERATURE REVIEW

  2025cites this paper
• From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management

  2025cites this paper
• Dissecting causal relationships between inflammatory factors, plasma metabolites, and nonalcoholic fatty liver disease: a mediating Mendelian randomization study.

  2025cites this paper
• Higher Residual and Metabolic Dysfunction-Associated Fatty Liver Disease Risk of the R-Enantiomer of Famoxadone in Mice.

  2025cites this paper
• The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.

  2025cites this paper
• Berberine prevents NAFLD and HCC by modulating metabolic disorders.

  2024cites this paper
• Bacteroides and NAFLD: pathophysiology and therapy

  2024cites this paper
• Different aspects of immunological profile in patients with Non-Alcoholic Fatty liver disease.

  2024cites this paper
• Mechanisms Underlying Obesity-induced Aβ Accumulation in Alzheimer's Disease: A Qualitative Review.

  2024cites this paper
• In Vitro Nonalcoholic Fatty Liver Disease Model Elucidating the Effect of Immune Environment on Disease Progression and Alleviation

  2024cites this paper
• Association between paravertebral muscle radiological parameter alterations and non-alcoholic fatty liver disease

  2024cites this paper
• Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Association between serum antibodies to oral microorganisms and nonalcoholic fatty liver disease in adults

  2024cites this paper
• Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.

  2024cites this paper
• Frontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022

  2023cites this paper
• Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus

  2023cites this paper
• Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the AMPK pathway and reshaping gut microbiota.

  2023cites this paper
• Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma

  2023cites this paper
• Myeloperoxidase-Sensitive T1 and T2 Switchable MR Imaging for Diagnosis of Nonalcoholic Steatohepatitis.

  2023cites this paper
• A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway

  2023cites this paper
• Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD)

  2023cites this paper
• Enhanced apoptotic index in hepatocytes, Kupffer cells, and inflammatory infiltrate showed positive correlation with hepatic lesion intensity, parasite load, and clinical status in naturally Leishmania-infected dogs.

  2023cites this paper
• Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies.

  2023cites this paper
• Cardioprotective Effects of Nano-Piperine Against Cypermethrin Toxicity Through Oxidative Stress, Histopathological and Immunohistochemical Studies in Male Wistar Rats

  2023cites this paper
• Monitoring physiological processes of fast-growing broilers during the whole life cycle: Changes of redox-homeostasis effected to trassulfuration pathway predicting the development of non-alcoholic fatty liver disease

  2023cites this paper
• Diet, sleep, and exercise in inflammatory skin diseases.

  2023cites this paper
• Chronic exposure to low concentration of MC-LR caused hepatic lipid metabolism disorder.

  2022cites this paper
• Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease

  2022cites this paper
• Inhibitory effect of water-soluble mulberry leaf extract on hepatic lipid accumulation in high-fat diet-fed rats via modulation of hepatic microRNA-221/222 expression and inflammation

  2022cites this paper
• Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis

  2022cites this paper
• Neopterin as an Inflammatory Biomarker in Patients with Non-alcoholic Fatty Liver Disease

  2022cites this paper
• Dietary EPA+DHA Mitigate Hepatic Toxicity and Modify the Oxylipin Profile in an Animal Model of Colorectal Cancer Treated with Chemotherapy

  2022cites this paper
• Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

  2022cites this paper
• Tyrosol Ameliorates Liver Inflammatory Response in a Mouse Model of Nonalcoholic Fatty Liver Disease (NFALD) by Regulating JAK1/STAT3

  2022influential citation
• Dynamic 3D genome reorganization during development and metabolic stress of the porcine liver

  2022cites this paper
• Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

  2022cites this paper
• Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond

  2022cites this paper
• Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway

  2022cites this paper
• The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosis

  2021cites this paper
• Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease

  2021cites this paper
• Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

  2021cites this paper
• Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions

  2021cites this paper
• Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease

  2021cites this paper
• The Role of Obesity in Predicting the Clinical Outcomes of COVID-19

  2021cites this paper
• Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study

  2021cites this paper
• Cadmium exposure modulates the gut-liver axis in an Alzheimer’s disease mouse model

  2021cites this paper
• Protective Effect of Gallic Acid against Nonalcoholic Fatty Liver Disease Induced by High Fat Diet

  2021cites this paper
• Metabolic parameters and gut microbiota composition of rats fed high-fat diets based on ruminant fat compared with hydrogenated vegetable fat

  2021cites this paper
• The Peculiar Trialogue between Pediatric Obesity, Systemic Inflammatory Status, and Immunity

  2021influential citation
• Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis

  2021cites this paper
• Role of exercise on visceral adiposity after spinal cord injury: a cardiometabolic risk factor

  2021cites this paper
• Saskatoon Berry Powder Reduces Hepatic Steatosis and Insulin Resistance in High Fat-High Sucrose Diet-Induced Obese Mice.

  2021cites this paper
• Liver-spleen axis in nonalcoholic fatty liver disease

  2021cites this paper
• Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights

  2021cites this paper
• Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)

  2021cites this paper
• Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice

  2021cites this paper
• Spirulina reduces diet-induced obesity through downregulation of lipogenic genes expression in Psammomys obesus

  2020cites this paper
• Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances

  2020cites this paper
• Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING

  2020cites this paper
• Inflammatory Milieu May Trigger Metabolic Changes in Migraine Attacks

  2020cites this paper
• Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease

  2020cites this paper
• Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression

  2020cites this paper
• STRUCTURED LIPID CONTAINING BEHENIC ACID VERSUS ORLISTAT FOR WEIGHT LOSS: AN EXPERIMENTAL STUDY IN MICE

  2020cites this paper
• Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis

  2020cites this paper
• A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• The Role of Elastography in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Evaluation the Predictors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients

  2020cites this paper
• Quercitrin Ameliorates Hyperlipidemia and Hepatic Steatosis in Ovariectomized Mice

  2020influential citation
• Attenuation of arsenic induced high fat diet exacerbated oxidative stress mediated hepatic and cardiac injuries in male Wistar rats by piperine involved antioxidative mechanisms.

  2020cites this paper
• Investigation of the Synergistic Effect of Brown Sugar, Longan, Ginger, and Jujube (Brown Sugar Longan Ginger Tea) on Antioxidation and Anti-Inflammation in In Vitro Models

  2020cites this paper
• Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality

  2020cites this paper
• The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis

  2020cites this paper
• Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver Tumors

  2019cites this paper
• Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents

  2019cites this paper
• Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.

  2019cites this paper
• Liver alterations in anorexia nervosa are not caused by insulin resistance

  2019cites this paper
• Pathogenesis of and major animal models used for nonalcoholic fatty liver disease

  2019cites this paper
• Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation

  2019cites this paper
• Role of cytokines in pathogenesis and progression of nonalcoholic steatohepatitis

  2019cites this paper
• Is Nrf2-ARE a potential target in NAFLD mitigation?

  2019cites this paper
• Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease.

  2019cites this paper
• Interrelation of liver vascularity to non‐alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats

  2019cites this paper
• (-)-Hydroxycitric Acid Suppresses Lipid Droplet Accumulation and Accelerates Energy Metabolism via Activation of the Adiponectin-AMPK Signaling Pathway in Broiler Chickens.

  2019cites this paper
• Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).

  2018cites this paper
• Honokiol Improves Liver Steatosis in Ovariectomized Mice

  2018cites this paper
• Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study

  2018cites this paper
• Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk

  2018cites this paper
• Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children

  2018cites this paper
• Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet

  2018cites this paper
• Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease

  2018cites this paper
• Protective effect of curcumin on the liver of high fat diet-fed rats

  2018cites this paper
• IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.

  2018cites this paper
• Mechanisms of NAFLD development and therapeutic strategies

  2018cites this paper
• Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease

  2018influential citation
• Liver-Microbiome Axis in Health and Disease.

  2018cites this paper
• Down‐regulation of microRNA‐375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non‐alcoholic fatty liver disease

  2018cites this paper
• Association between bedtime and the prevalence of newly diagnosed non‐alcoholic fatty liver disease in adults

  2018cites this paper